Gumapac, Baby Girl .
HRN: 22-87-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2023
AMPICILLIN 250MG (VIAL)
04/18/2023
04/25/2023
IV
150mg
Q12hrs
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes